{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T18:25:07Z","timestamp":1772735107380,"version":"3.50.1"},"reference-count":161,"publisher":"Informa UK Limited","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Neurological Research"],"DOI":"10.1080\/01616412.2026.2640120","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T17:30:59Z","timestamp":1772731859000},"page":"1-21","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["The potential role of metformin in multiple sclerosis: good or bad, and what\u2019s the lesson"],"prefix":"10.1080","author":[{"given":"Ali Abdullah","family":"AlAseeri","sequence":"first","affiliation":[{"name":"Prince Sattam bin Abdulaziz University","place":["Al-Kharj, Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3097-2962","authenticated-orcid":false,"given":"Hayder M.","family":"Al-Kuraishy","sequence":"additional","affiliation":[{"name":"Mustansiriyah University","place":["Baghdad, Iraq"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8284-8897","authenticated-orcid":false,"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[{"name":"Head of Jabir ibn Hayyan Medical University","place":["Najaf, Iraq"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0039-492X","authenticated-orcid":false,"given":"Duaa","family":"Eliwa","sequence":"additional","affiliation":[{"name":"Tanta University","place":["Tanta, Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7817-425X","authenticated-orcid":false,"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[{"name":"Damanhour University","place":["Damanhour, Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.4103\/2070-1128.248840"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4318-z"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14020122"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202312_34583"},{"issue":"8","key":"e_1_3_5_6_1","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/bcp.14320","article-title":"Metformin disposition-a 40-year-old mystery","volume":"86","author":"Tucker GT","year":"2020","unstructured":"Tucker GT, Wesolowski CA. Metformin disposition-a 40-year-old mystery. Br J Clin Pharmacol. 2020;86(8):1452\u20131453.","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2017.04.078"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2022.01.008"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.4103\/JMAU.JMAU_63_20"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.4103\/japtr.JAPTR_273_18"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413660"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113686"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells14141064"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108985"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15111361"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaa023"},{"issue":"2","key":"e_1_3_5_17_1","doi-asserted-by":"crossref","first-page":"e01063","DOI":"10.1002\/prp2.1063","article-title":"Pros and cons for statins use and risk of Parkinson\u2019s disease: an updated perspective","volume":"11","author":"Al-Kuraishy HM","year":"2023","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, et al. Pros and cons for statins use and risk of Parkinson\u2019s disease: an updated perspective. Pharmacol Res Perspect. 2023;11(2):e01063.","journal-title":"Pharmacol Res Perspect"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.4103\/bbrj.bbrj_7_20"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04431-8"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/biology13050302"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.172984"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17519"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119343"},{"issue":"3","key":"e_1_3_5_24_1","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s10787-023-01163-7","article-title":"Long-term use of metformin and Alzheimer\u2019s disease: beneficial or detrimental effects","volume":"31","author":"Al-Kuraishy HM","year":"2023","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Saad HM, et al. Long-term use of metformin and Alzheimer\u2019s disease: beneficial or detrimental effects. Inflammopharmacology. 2023;31(3):1107\u20131115.","journal-title":"Inflammopharmacology"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17965"},{"issue":"4","key":"e_1_3_5_26_1","first-page":"3","article-title":"Metformin role in Parkinson\u2019s disease: a double-sword effect","volume":"479","author":"Alrouji M","year":"2023","unstructured":"Alrouji M, Al-Kuraishy H, Al-Gareeb A, et al. Metformin role in Parkinson\u2019s disease: a double-sword effect. Mol Cell Biochem. 2023;479(4):3.","journal-title":"Mol Cell Biochem"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-023-00833-4"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2017.0072"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148648"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22243"},{"issue":"7","key":"e_1_3_5_31_1","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00210-023-02434-4","article-title":"Morus alba: a comprehensive phytochemical and pharmacological review","volume":"396","author":"Batiha GE","year":"2023","unstructured":"Batiha GE, Al-Snafi AE, Thuwaini MM, et al. Morus alba: a comprehensive phytochemical and pharmacological review. Naunyn Schmiedebergs Arch Pharmacol. 2023;396(7):1399\u20131413.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70064-8"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-017-0086-4"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2011.03.001"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2021.1978843"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.996469"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012323"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/npr2.70039"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2025.111333"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.1604"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18102048"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1583"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2019.6890"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa255"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00217"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115904"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp106"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.110"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010909"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-023-10173-6"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2011.06.006"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1254586"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom12020222"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00718-z"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147432"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.2174\/1566524022666211222161637"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189753"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00581-x"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2020-0292"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1177\/17562864221137129"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-023-01163-7"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-023-04771-7"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1422912"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05098-8"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12017-025-08857-x"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2025.2506292"},{"key":"e_1_3_5_67_1","doi-asserted-by":"crossref","first-page":"644295","DOI":"10.3389\/fmed.2021.644295","article-title":"COVID-19 and risk of acute ischemic stroke and acute lung injury in patients with type II diabetes mellitus: the anti-inflammatory role of metformin","volume":"8","author":"Al-Kuraishy HM","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alblihed M, et al. COVID-19 and risk of acute ischemic stroke and acute lung injury in patients with type II diabetes mellitus: the anti-inflammatory role of metformin. Front Med (Lausanne). 2021;8:644295.","journal-title":"Front Med (Lausanne)"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05126-7"},{"issue":"1","key":"e_1_3_5_69_1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12035-025-05303-8","article-title":"Metformin as a neuroendocrine modulator in catamenial epilepsy: interplay with sex hormones and neurosteroids","volume":"63","author":"Alameen AAM","year":"2025","unstructured":"Alameen AAM, Al-Kuraishy HM, Al-Maiahy TJ, et al. Metformin as a neuroendocrine modulator in catamenial epilepsy: interplay with sex hormones and neurosteroids. Mol Neurobiol. 2025;63(1):224.","journal-title":"Mol Neurobiol"},{"issue":"12","key":"e_1_3_5_70_1","doi-asserted-by":"crossref","first-page":"8005","DOI":"10.4049\/jimmunol.0803563","article-title":"Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis","volume":"182","author":"Nath N","year":"2009","unstructured":"Nath N, Khan M, Paintlia MK, et al. Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. J Immunol. 2009;182(12):8005\u20138014.","journal-title":"J Immunol"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-019-00019-8"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-021-00417-y"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2019.08.015"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2023.1254303"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40199-019-00286-z"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-014-9632-2"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112961"},{"issue":"3","key":"e_1_3_5_78_1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10735-019-09824-0","article-title":"Oligoprotective effect of metformin through the AMPK-dependent on restoration of mitochondrial hemostasis in the cuprizone-induced multiple sclerosis model","volume":"50","author":"Largani SHH","year":"2019","unstructured":"Largani SHH, Borhani-Haghighi M, Pasbakhsh P, et al. Oligoprotective effect of metformin through the AMPK-dependent on restoration of mitochondrial hemostasis in the cuprizone-induced multiple sclerosis model. J Mol Histol. 2019;50(3):263\u2013271.","journal-title":"J Mol Histol"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2014.05.002"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25136996"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094758"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105434"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.4807"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.07.001"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-12113-2"},{"key":"e_1_3_5_86_1","unstructured":"A phase I double blind study of metformin acting on endogenous neural progenitor cells in children with multiple sclerosis. 2019."},{"key":"e_1_3_5_87_1","unstructured":"Ccmr two: a phase IIa randomised double-blind placebo-controlled trial of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy. 2021."},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32346-2"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1362629"},{"key":"e_1_3_5_90_1","article-title":"Relationship between metformin, monoacylglycerol lipase expression, cognition and emotion recognition in people with multiple sclerosis and comorbid type II diabetes","author":"Walker L","year":"2024","unstructured":"Walker L, Ramani S, Pumphrey JD, et al. Relationship between metformin, monoacylglycerol lipase expression, cognition and emotion recognition in people with multiple sclerosis and comorbid type II diabetes. Cognition Emotion MSType II Diabetes. 2024;420:1-14.","journal-title":"Cognition Emotion MSType II Diabetes"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.984559"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102565"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)78143-5"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00400"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph18040486"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21175957"},{"key":"e_1_3_5_97_1","doi-asserted-by":"crossref","first-page":"642181","DOI":"10.3389\/fcvm.2021.642181","article-title":"Case report: hyperbilirubinemia in Gilbert syndrome attenuates COVID-19-induced metabolic disturbances","volume":"8","author":"Al-Kuraishy HM","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Abdullah SM, et al. Case report: hyperbilirubinemia in Gilbert syndrome attenuates COVID-19-induced metabolic disturbances. Front Cardiovasc Med. 2021;8:642181.","journal-title":"Front Cardiovasc Med"},{"key":"e_1_3_5_98_1","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.2147\/DDDT.S248892","article-title":"Neuroprotective effect of mesenchymal stromal cell-derived extracellular vesicles against cerebral ischemia-reperfusion-induced neural functional injury: a pivotal role for AMPK and JAK2\/STAT3\/NF-\u03baB signaling pathway modulation","volume":"14","author":"Han M","year":"2020","unstructured":"Han M, Cao Y, Xue H, et al. Neuroprotective effect of mesenchymal stromal cell-derived extracellular vesicles against cerebral ischemia-reperfusion-induced neural functional injury: a pivotal role for AMPK and JAK2\/STAT3\/NF-\u03baB signaling pathway modulation. Drug Des Devel Ther. 2020;14:2865\u20132876.","journal-title":"Drug Des Devel Ther"},{"key":"e_1_3_5_99_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.expneurol.2017.08.013","article-title":"Ampk activation: role in the signaling pathways of neuroinflammation and neurodegeneration","volume":"298","author":"Peixoto CA","year":"2017","unstructured":"Peixoto CA, Oliveira WH, Ara\u00fajo S, et al. Ampk activation: role in the signaling pathways of neuroinflammation and neurodegeneration. Exp Neurol. 2017;298(Pt A):31\u201341.","journal-title":"Exp Neurol"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-022-00956-6"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2021.12.030"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15630"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-022-07822-2"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.05.106"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.186.Supp.148.20"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501549"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2021.12.012"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-023-01399-3"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00951"},{"key":"e_1_3_5_110_1","volume-title":"Targeting cancer-and chemotherapy-induced anorexia and cachexia using the GDF15\/GFRAL signalling system","author":"Shoop RH","year":"2023","unstructured":"Shoop RH. Targeting cancer-and chemotherapy-induced anorexia and cachexia using the GDF15\/GFRAL signalling system. The University of Manchester (United Kingdom); 2023."},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00915"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103830"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu16050734"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-020-02459-1"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2403081"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1911-y"},{"issue":"5","key":"e_1_3_5_117_1","doi-asserted-by":"crossref","first-page":"R635","DOI":"10.1152\/ajpregu.00189.2022","article-title":"Neither GLP-1 receptors nor GFRAL neurons are required for aversive or anorectic response to DON (vomitoxin)","volume":"324","author":"Patel AR","year":"2023","unstructured":"Patel AR, Frikke-Schmidt H, Sabatini PV, et al. Neither GLP-1 receptors nor GFRAL neurons are required for aversive or anorectic response to DON (vomitoxin). Am J Physiol Regul Integr Comp Physiol. 2023;324(5):R635\u201344.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"e_1_3_5_118_1","doi-asserted-by":"crossref","first-page":"490842","DOI":"10.1155\/2015\/490842","article-title":"Gdf-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective","volume":"2015","author":"Adela R","year":"2015","unstructured":"Adela R, Banerjee SK. Gdf-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective. J Diabetes Res. 2015;2015:490842.","journal-title":"J Diabetes Res"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.116429"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-023-01255-4"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2023.578268"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000675"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-021-00529-7"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2020.10.004"},{"issue":"2","key":"e_1_3_5_125_1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/15548627.2023.2259281","article-title":"The beneficial role of autophagy in multiple sclerosis","volume":"20","author":"Al-Kuraishy HM","year":"2024","unstructured":"Al-Kuraishy HM, Jabir MS, Al-Gareeb AI, et al. The beneficial role of autophagy in multiple sclerosis. Yes No Autophagy. 2024;20(2):259\u2013274.","journal-title":"Yes No Autophagy"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-023-00742-2"},{"issue":"12","key":"e_1_3_5_127_1","doi-asserted-by":"crossref","first-page":"e70010","DOI":"10.1111\/1753-0407.70010","article-title":"Autophagy modulators in type 2 diabetes: a new perspective","volume":"16","author":"Zaidalkilani AT","year":"2024","unstructured":"Zaidalkilani AT, Al-Kuraishy HM, Fahad EH, et al. Autophagy modulators in type 2 diabetes: a new perspective. J Diabetes. 2024;16(12):e70010.","journal-title":"J Diabetes"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26175163"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12092051"},{"issue":"13","key":"e_1_3_5_130_1","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jcmm.17784","article-title":"Nf-\u03bab\/nlrp3 inflammasome axis and risk of Parkinson\u2019s disease in type 2 diabetes mellitus: a narrative review and new perspective","volume":"27","author":"Alrouji M","year":"2023","unstructured":"Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, et al. Nf-\u03bab\/nlrp3 inflammasome axis and risk of Parkinson\u2019s disease in type 2 diabetes mellitus: a narrative review and new perspective. J Cell Mol Med. 2023;27(13):1775\u20131789.","journal-title":"J Cell Mol Med"},{"key":"e_1_3_5_131_1","doi-asserted-by":"crossref","first-page":"603710","DOI":"10.3389\/fncel.2020.603710","article-title":"Autophagy in multiple sclerosis: two sides of the same coin","volume":"14","author":"Misrielal C","year":"2020","unstructured":"Misrielal C, Mauthe M, Reggiori F, et al. Autophagy in multiple sclerosis: two sides of the same coin. Front Cell Neurosci. 2020;14:603710.","journal-title":"Front Cell Neurosci"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.1515\/ntrev-2023-0127"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.1515\/ntrev-2023-0148"},{"issue":"1","key":"e_1_3_5_134_1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cmet.2020.04.015","article-title":"Metformin enhances autophagy and normalizes mitochondrial function to alleviate aging-associated inflammation","volume":"32","author":"Bharath LP","year":"2020","unstructured":"Bharath LP, Agrawal M, McCambridge G, et al. Metformin enhances autophagy and normalizes mitochondrial function to alleviate aging-associated inflammation. Cell Metab. 2020;32(1):44\u201355.e6.","journal-title":"Cell Metab"},{"key":"e_1_3_5_135_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.117.109512"},{"key":"e_1_3_5_136_1","doi-asserted-by":"publisher","DOI":"10.1002\/glia.22433"},{"key":"e_1_3_5_137_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-020-00590-7"},{"key":"e_1_3_5_138_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158077"},{"key":"e_1_3_5_139_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092346"},{"issue":"6","key":"e_1_3_5_140_1","doi-asserted-by":"crossref","first-page":"e002550","DOI":"10.1161\/JAHA.112.002550","article-title":"Growth differentiation factor-15 deficiency inhibits atherosclerosis progression by regulating interleukin-6-dependent inflammatory response to vascular injury","volume":"1","author":"Bonaterra GA","year":"2012","unstructured":"Bonaterra GA, Z\u00fcgel S, Thogersen J, et al. Growth differentiation factor-15 deficiency inhibits atherosclerosis progression by regulating interleukin-6-dependent inflammatory response to vascular injury. J Am Heart Assoc. 2012;1(6):e002550.","journal-title":"J Am Heart Assoc"},{"key":"e_1_3_5_141_1","doi-asserted-by":"crossref","first-page":"112193","DOI":"10.1016\/j.biopha.2021.112193","article-title":"Arginine vasopressin and pathophysiology of COVID-19: an innovative perspective","volume":"143","author":"Al-Kuraishy HM","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Qusti S, et al. Arginine vasopressin and pathophysiology of COVID-19: an innovative perspective. Biomed Pharmacother. 2021;143:112193.","journal-title":"Biomed Pharmacother"},{"key":"e_1_3_5_142_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-023-01082-1"},{"key":"e_1_3_5_143_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10082032"},{"key":"e_1_3_5_144_1","doi-asserted-by":"publisher","DOI":"10.4103\/bbrj.bbrj_103_20"},{"key":"e_1_3_5_145_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04003-z"},{"key":"e_1_3_5_146_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05113-y"},{"key":"e_1_3_5_147_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-025-02000-9"},{"key":"e_1_3_5_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110874"},{"key":"e_1_3_5_149_1","doi-asserted-by":"publisher","DOI":"10.5115\/acb.2017.50.1.48"},{"key":"e_1_3_5_150_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.1.338"},{"key":"e_1_3_5_151_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203057"},{"key":"e_1_3_5_152_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-023-03667-3"},{"key":"e_1_3_5_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106348"},{"key":"e_1_3_5_154_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2012-111649"},{"key":"e_1_3_5_155_1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainresbull.2021.09.008","article-title":"Bmscs-exosomes containing GDF-15 alleviated SH-SY5Y cell injury model of Alzheimer\u2019s disease via AKT\/GSK-3\u03b2\/\u03b2-catenin","volume":"177","author":"Xiong WP","year":"2021","unstructured":"Xiong WP, Yao WQ, Wang B, et al. Bmscs-exosomes containing GDF-15 alleviated SH-SY5Y cell injury model of Alzheimer\u2019s disease via AKT\/GSK-3\u03b2\/\u03b2-catenin. Brain Res Bull. 2021;177:92\u2013102.","journal-title":"Brain Res Bull"},{"key":"e_1_3_5_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2012.11.025"},{"key":"e_1_3_5_157_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01817-4"},{"issue":"12","key":"e_1_3_5_158_1","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/alz.12161","article-title":"Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer\u2019s disease, and the role APOE carrier status","volume":"16","author":"Wu CY","year":"2020","unstructured":"Wu CY, Ouk M, Wong YY, et al. Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer\u2019s disease, and the role APOE carrier status. Alzheimers Dement. 2020;16(12):1663\u20131673.","journal-title":"Alzheimers Dement"},{"key":"e_1_3_5_159_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.838173"},{"key":"e_1_3_5_160_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0229"},{"key":"e_1_3_5_161_1","doi-asserted-by":"crossref","first-page":"578852","DOI":"10.1016\/j.jneuroim.2025.578852","article-title":"Efficacy and tolerability of metformin as an adjuvant therapy in patients with relapse-remitting multiple sclerosis receiving interferon beta 1a: a randomized pilot trial","volume":"412","author":"Abdelgaied MY","year":"2025","unstructured":"Abdelgaied MY, Abdelgawad O, Rashad MH, et al. Efficacy and tolerability of metformin as an adjuvant therapy in patients with relapse-remitting multiple sclerosis receiving interferon beta 1a: a randomized pilot trial. J Neuroimmunol. 2025;412:578852.","journal-title":"J Neuroimmunol"},{"key":"e_1_3_5_162_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40495-025-00395-1"}],"container-title":["Neurological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/01616412.2026.2640120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T17:31:04Z","timestamp":1772731864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/01616412.2026.2640120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":161,"alternative-id":["10.1080\/01616412.2026.2640120"],"URL":"https:\/\/doi.org\/10.1080\/01616412.2026.2640120","relation":{},"ISSN":["0161-6412","1743-1328"],"issn-type":[{"value":"0161-6412","type":"print"},{"value":"1743-1328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yner20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yner20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}